Lichen
Conditions
Brief summary
Achievement of IGA response (absolute IGA score ≤2) at Week 16
Detailed description
Achievement of 2 points improvement in the IGA at Week 32, Achievement of DLQI 0/1 score at Week 16 and Week 32, PGIS at Week 16 and Week 32, PGIC at Week 16 and Week 32, Adverse events, laboratory values, vital signs from baseline to end of study visit analysis, Absolute and relative change in REU, OLPSSM and NRS score at Week 16 and Week 32, Absolute and relative change in LPPAI and SCALPDEX Questionnaire score at Week 16 and Week 32
Interventions
DRUGPlacebo is identifical in composition to rinovq but does not contain the substance medical
Sponsors
Centre Hospitalier Universitaire De Nice
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Achievement of IGA response (absolute IGA score ≤2) at Week 16 | — |
Secondary
| Measure | Time frame |
|---|---|
| Achievement of 2 points improvement in the IGA at Week 32, Achievement of DLQI 0/1 score at Week 16 and Week 32, PGIS at Week 16 and Week 32, PGIC at Week 16 and Week 32, Adverse events, laboratory values, vital signs from baseline to end of study visit analysis, Absolute and relative change in REU, OLPSSM and NRS score at Week 16 and Week 32, Absolute and relative change in LPPAI and SCALPDEX Questionnaire score at Week 16 and Week 32 | — |
Outcome results
None listed